Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers

BACKGROUND: Chemoprevention with anti-estrogens, such as tamoxifen, raloxifene or aromatase inhibitors, have been shown to reduce breast cancer risk in randomized controlled trials; however, uptake among women at high-risk for developing breast cancer remains low. The aim of this study is to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Tarsha, Silverman, Thomas, Guzman, Ashlee, McGuinness, Julia E., Trivedi, Meghna S., Kukafka, Rita, Crew, Katherine D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354269/
https://www.ncbi.nlm.nih.gov/pubmed/35927732
http://dx.doi.org/10.1186/s12911-022-01954-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354269/
https://www.ncbi.nlm.nih.gov/pubmed/35927732
http://dx.doi.org/10.1186/s12911-022-01954-y

Ejemplares similares